All Pigmented Skin TumorsNCT07863076
Dermoscopic and Histopathological Patterns of Pigmented Skin Lesions
An observational study of All Pigmented Skin Tumors, run by Sohag University at 1 site in Egypt.
Trial summary
1. To describe and analyze the characteristic dermoscopic features of various kinds of pigmented melanocytic and non-melanocytic skin lesions among patients attending the outpatient clinic in Sohag University Hospitals. 2. Read more about this study
- Who is it for?
- Ages 1 year and olderHealthy volunteers can take part
- Conditions the study is for
- All Pigmented Skin Tumors
- How many people
- 400 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Oct 2026to Dec 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 year and older
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: All patients presenting with pigmented skin lesions
Who may be able to join
- • Patients with clinically diagnosed or suspected pigmented skin lesions including; pigmented nevi (typical and atypical), seborrheic keratosis, pigmented actinic keratosis, pigmented BCC, suspected melanoma
- All facial, acral, mucosal and trunk pigmented lesions will be included
Who cannot join
- • Poor quality dermoscopic images that are unsuitable for interpretation.
- Lesions with difficulty in obtaining histopathological specimens
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site, 1 recruiting
- Recruiting
Sohag University Hospitals
Sohag, 82524
Doaa Abdelbaset, 01022330810, doaaabdelbaset23@gmail.com
About this study
Official title: Dermoscopic and Histopathological Patterns of Pigmented Skin Lesions: A Cross-sectional Analytical Study.
- To describe and analyze the characteristic dermoscopic features of various kinds of pigmented melanocytic and non-melanocytic skin lesions among patients attending the outpatient clinic in Sohag University Hospitals.
- To correlate dermoscopic findings with clinical and histopathological diagnoses (when available).
- To assess the diagnostic value of dermoscopy in differentiating benign from malignant pigmented skin lesions.
- Conditions
- All Pigmented Skin Tumors
- Keywords
- dermoscopy, pigmented skin lesion
What is being measured
The primary outcome is the main question the study is designed to answer.
About 400 patient in one year presenting with pigmented skin lesion will be diagnosed clinically and dermoscopy and results will be correlated with histopathological results
- To describe and analyze the characteristic dermoscopic features of various kinds of pigmented melanocytic and non-melanocytic skin lesions detecting and differentiating benign and malignant lesions among patients attending the outpatient clinic in Sohag University Hospitals.
Measured: october 2026 to october 2027
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Oct 2026
- Study start1 Oct 2026 (estimated)
- Primary completion31 Oct 2027 (estimated)
- Study completionDec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for All Pigmented Skin TumorsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 400 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Doaa Gaber Abdel baset, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07863076
- Sponsor's protocol ID
- Soh-Med-26-9-11PD
- Status last verified
- Sep 2026
- First submitted
- 27 Sep 2026
- Last updated
- 7 Oct 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 7 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Dermoscopic and Histopathological Patterns of Pigmented Skin Lesions: A Cross-sectional Analytical Study.
- ClinicalTrials.gov ID
- NCT07863076
- Acronym / sponsor ID
- Soh-Med-26-9-11PD
- Conditions
- All Pigmented Skin Tumors
- Keywords
- dermoscopy, pigmented skin lesion
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 400 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 1 Oct 2026 (estimated)
- Primary completion
- 31 Oct 2027 (estimated)
- Study completion
- Dec 2027 (estimated)
- First posted
- 7 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
- To describe and analyze the characteristic dermoscopic features of various kinds of pigmented melanocytic and non-melanocytic skin lesions among patients attending the outpatient clinic in Sohag University Hospitals.
- To correlate dermoscopic findings with clinical and histopathological diagnoses (when available).
- To assess the diagnostic value of dermoscopy in differentiating benign from malignant pigmented skin lesions.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 1 year and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- All patients presenting with pigmented skin lesions
Key inclusion criteria (2 listed)
- • Patients with clinically diagnosed or suspected pigmented skin lesions including; pigmented nevi (typical and atypical), seborrheic keratosis, pigmented actinic keratosis, pigmented BCC, suspected melanoma
Key exclusion criteria (2 listed)
- • Poor quality dermoscopic images that are unsuitable for interpretation.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
About 400 patient in one year presenting with pigmented skin lesion will be diagnosed clinically and dermoscopy and results will be correlated with histopathological results
Time frame: october 2026 to october 2027
1) To describe and analyze the characteristic dermoscopic features of various kinds of pigmented melanocytic and non-melanocytic skin lesions detecting and differentiating benign and malignant lesions among patients attending the outpatient clinic in Sohag University Hospitals.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Oct 2026.
- Individual participant dataSharing planned: Undecided
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of All Pigmented Skin Tumors, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Doaa Gaber Abdelbaset, Lecturer (01022330810, doaaabdelbaset23@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
About 400 patient in one year presenting with pigmented skin lesion will be diagnosed clinically and dermoscopy and results will be correlated with histopathological results (time frame: october 2026 to october 2027). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026.